DocSym
β
Searchsearch
Search
(X62) Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
More details coming soon
139 312 in individuals diagnosis intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified confirmed
17 720 deaths with diagnosis intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
13% mortality rate associated with the disease intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
Diagnosis intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified is diagnosed Men are 29.56% more likely than Women
90 246
Men receive the diagnosis intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
11 144 (12.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
49 066
Women receive the diagnosis intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
6 576 (13.4 %)Died from this diagnosis.
Risk Group for the Disease intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified - Men aged 30-34 and Women aged 15-19
In Men diagnosis is most often set at age 10-64, 70-79
Less common in men the disease occurs at Age 0-9, 65-69, 80-95+Less common in women the disease occurs at Age 0-9, 70-79, 85-95+
In Women diagnosis is most often set at age 10-69, 80-84
Disease Features intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
Absence or low individual and public risk
Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified - what does this mean
Intentional self-poisoning by and exposure to narcotics and psychodysleptics (hallucinogens) not elsewhere classified occurs when an individual intentionally ingests a substance that has a mind-altering effect and is not classified in any other category. these substances can be found in both natural and synthetic forms and can cause hallucinations, changes in mood, and altered states of consciousness.
What happens during the disease - intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified is a condition caused by the intentional ingestion of substances with psychoactive properties for the purpose of altering one's mental state. this condition is characterized by changes in cognition, perception, and mood, as well as physical symptoms such as nausea, vomiting, and respiratory depression. in severe cases, the ingestion of these substances can lead to coma, seizures, and even death.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination to assess the patient's condition and rule out other causes of the symptoms.
- Laboratory tests to detect the presence of drugs and/or metabolites in the patient's blood or urine.
- Psychological evaluation to assess the patient's mental state and determine if there is any underlying psychological disorder.
- Imaging tests such as CT scan or MRI to check for organ damage.
- Toxicology screening to detect the presence of drugs and/or metabolites in the patient's blood or urine.
- Treatment with supportive care, including fluids and electrolytes, and medications to counteract the effects of the drugs.
- Counseling and psychotherapy to help the patient cope with the psychological effects of the drugs.
Treatment and Medical Assistance
Main goal of the treatment: To reduce the risk of further harm to the patient due to intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified.
- Monitoring the patient's vital signs and mental status.
- Administering medications to reduce symptoms of intoxication and withdrawal.
- Providing psychosocial interventions to help the patient cope with the effects of the drugs.
- Providing education about the risks of further drug use.
- Referring the patient to a substance abuse treatment program.
- Providing counseling and support to family members.
- Referring the patient to a mental health professional for further assessment and treatment.
6 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified - Prevention
The best way to prevent intentional self-poisoning by and exposure to narcotics and psychodysleptics is to ensure that these substances are not easily accessible and to educate people about the potential risks and dangers of using them. additionally, providing mental health support and access to treatment for those who are struggling with addiction can help reduce the risk of intentional self-poisoning.